Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × NETWORK × Amyloidosis × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 11 INDUSTRY 3 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 72 Lung Neoplasms 64 Breast Neoplasms 63 Lymphoma 58 Ovarian Neoplasms 51 Leukemia 44 Sarcoma 43 Prostatic Neoplasms 37 Multiple Myeloma 36 Head and Neck Neoplasms 36 Central Nervous System Neoplasms 36 Squamous Cell Carcinoma of Head and Neck 32 Colorectal Neoplasms 31 Carcinoma, Ovarian Epithelial 30 Melanoma 29 Rectal Neoplasms 28 Neoplasm Metastasis 27 Uterine Cervical Neoplasms 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, Large B-Cell, Diffuse 26 Brain Neoplasms 26 Urinary Bladder Neoplasms 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Fallopian Tube Neoplasms 23 Leukemia, Myeloid, Acute 22 Endometrial Neoplasms 22 Glioblastoma 21 Adenocarcinoma of Lung 21 Lymphoma, Mantle-Cell 18 Gliosarcoma 17

Interventions

pomalidomide 1 isatuximab 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡